QNRX Earnings

Quarterly EPS
$-13.68
Q2 2024
$-16.29
Q3 2024
$-12.96
Q4 2024
$-6.50
Q1 2025
$-6.28
Q2 2025
$-6.71
Q3 2025
$-1.73
Q4 2025
$-1.77
Q1 2026
Latest RevenueN/A
Latest Net Income-4997735
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$1.770-4997735+72.8%
Q4 2025-$1.730-4348373+86.7%
Q3 2025-$6.710-3948165+58.8%
Q2 2025-$6.280-3695938+54.1%
Q1 2025-$6.500-3812179+83.2%
Q4 2024-$12.960-2311274+82.1%
Q3 2024-$16.290-2349885+76.1%
Q2 2024-$13.680-1974033+81.6%
Q1 2024-$38.730-2327280
Q4 2023-$72.320-2049878
Q3 2023-$68.250-1926679
Q2 2023-$74.550-2106947
Quoin Pharmaceuticals, Ltd. American (QNRX) — Earnings